Noninvasive imaging biomarkers of chronic liver disease severity and prognosis

Yavuz B. Taktak, Burak Gultekin, Muhammed Enes Tasci, Oyku Ikizgul, Halil Ertugrul Aktas, Andrea M. Bejar, Kerem Arisin, Esin Ozkan, Irem Sena Bayrak, Ece Busra Elustu, Ayse Ece Taymez, Ibrahim H. Akkis, Can Deniz Yokus, Maryam Haghshomar, Derin Sanal, Naci Senkal, Elif Keles, Alpay Medetalibeyoglu, Gulbiz Dagoglu Kartal, Amir A. Borhani, Daniela P. Ladner, Sabahattin Kaymakoglu, Gorkem Durak, Sukru Mehmet Erturk, Ulas Bagci

Abdominal Radiology

Abstract

PURPOSE: To evaluate whether MRI-derived functional and morphologic biomarkers are associated with clinical severity and prognosis in chronic liver disease (CLD).

MATERIALS AND METHODS: In this retrospective single-center study, 165 adults with chronic liver disease (CLD) who underwent gadoxetic acid-enhanced MRI were included. Functional Liver Imaging Score (FLIS) was assessed on 20-min hepatobiliary-phase images, and Liver Surface Nodularity (LSN) was measured on contrast-enhanced axial T1-weighted images using semi-automated software. Spearman correlation analysis was performed for associations with Model for End-Stage Liver Disease 3.0 (MELD 3.0), and Albumin-Bilirubin score (ALBI). Time-to-event analyses for liver transplantation or death within 4 years were performed using Kaplan-Meier analysis and Cox proportional hazards models. Receiver operating characteristic (ROC) analysis was used to evaluate the performance of FLIS for predicting 1-year transplant-free survival (TFS).

RESULTS: FLIS showed moderate inverse correlations with MELD 3.0 (ρ = - 0.532, p < 0.001) and ALBI score (ρ = - 0.541, p < 0.001). LSN showed weak positive correlations with MELD 3.0 (ρ = 0.154, p = 0.049) and ALBI score (ρ = 0.184, p = 0.018). In univariable Cox analysis, older age, lower FLIS, higher MELD 3.0, higher ALBI score, and LSN cutoff ≥ 3 were associated with a higher risk of liver transplantation/death. In multivariable analysis, age (hazard ratio (HR), 1.05; p < 0.001), MELD 3.0 (HR, 1.08; p = 0.003) and FLIS group (0-3 vs 4-6 points; HR, 2.39; p = 0.007) remained independently associated with liver transplantation or death. For 1-year TFS, FLIS with an optimal cutoff of ≤ 3 yielded an area under the curve (AUC) of 0.71 (95% confidence interval (CI), 0.61-0.82).

CONCLUSION: Our findings suggest that MRI-derived functional and morphologic biomarkers, particularly FLIS, may provide noninvasive imaging markers of disease severity and prognosis in patients with CLD. Prospective studies with long-term clinical outcomes are needed to define their role in risk stratification and transplant decision-making.

Abstract source

This retrospective, single-center study evaluated MRI-derived functional and morphologic biomarkers in chronic liver disease. Functional Liver Imaging Score was associated with disease severity and transplant-free survival, but prospective studies are needed to establish its role in risk assessment.

Summary

The study evaluated whether MRI-derived Functional Liver Imaging Score (FLIS), a measure based on liver enhancement, bile excretion, and the portal vein sign, and Liver Surface Nodularity (LSN), a measure of liver-surface irregularity, were associated with chronic liver disease severity and outcomes. The retrospective, single-center analysis included 165 adults who underwent gadoxetic acid-enhanced MRI. FLIS showed moderate correlations with MELD 3.0 and Albumin-Bilirubin scores, while LSN showed weak correlations with both measures.

In multivariable analysis, lower FLIS remained associated with liver transplantation or death within four years. FLIS at a cutoff of 3 or lower had an area under the curve of 0.71 for predicting one-year transplant-free survival. The authors note that the study did not establish incremental prognostic value beyond existing clinical scores; they call for prospective studies to assess the biomarkers’ potential role in risk assessment and transplant decision-making. Read the published article.

Cite this work

Yavuz B. Taktak, Burak Gultekin, Muhammed Enes Tasci, Oyku Ikizgul, Halil Ertugrul Aktas, Andrea M. Bejar, Kerem Arisin, Esin Ozkan, Irem Sena Bayrak, Ece Busra Elustu, Ayse Ece Taymez, Ibrahim H. Akkis, Can Deniz Yokus, Maryam Haghshomar, Derin Sanal, Naci Senkal, Elif Keles, Alpay Medetalibeyoglu, Gulbiz Dagoglu Kartal, Amir A. Borhani, Daniela P. Ladner, Sabahattin Kaymakoglu, Gorkem Durak, Sukru Mehmet Erturk, Ulas Bagci (2026). Noninvasive imaging biomarkers of chronic liver disease severity and prognosis. Abdominal Radiology https://doi.org/10.1007/s00261-026-05866-7

BibTeX